Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_assertion type Assertion NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_head.
- NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_assertion description "[The NAT2 gene polymorphism was not associated with susceptibility to IBD in Chinese populations, but the NAT2 slow acetylator genotypes were significantly associated with SP dose-related adverse effects of SASP in the treatment of IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_provenance.
- NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_assertion evidence source_evidence_literature NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_provenance.
- NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_assertion SIO_000772 17377643 NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_provenance.
- NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_assertion wasDerivedFrom befree-20150227 NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_provenance.
- NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_assertion wasGeneratedBy ECO_0000203 NP217549.RADAuxBeCL2OR2Q5jsuOq-GhKugEWn5YHoV4buk31my94130_provenance.